Plan Your Day
Abbott Hub Sessions at TCT 2023
Hub Hours
- Tuesday, October 24 from 11:00 a.m. – 6:00 p.m.
- Wednesday, October 25 from 9:00 a.m. – 6:00 p.m.
- Thursday, October 26 from 9:00 a.m. – 4:00 p.m.
Tuesday, October 24
9:45 am – 9:55 am
Medtech Innovation
Robert Ford: Artificial Intelligence in Medtech Innovation
Moscone South | Exhibit Level | Innovation & Clinical Science Theater
10:00 a.m. – 10:08 a.m.
PCI
xDAPT: An AI Developed Individualized DAPT Model Using Data from XIENCE Trials
Moscone South | Exhibit Level | Innovation & Clinical Science Theater
11:00 a.m.– 12:00 p.m.
Transcatheter Mitral
Driven by Design: The Engineering & Evidence Behind 20 Years of MitraClip™ Therapy
Abbott HUB #3 Theater | Exhibit Hall
Presenters: Jason Rogers, MD; Paul Mahoney, MD, and Steven Bolling, MD
Next-Level Engagement: Talk with Abbott engineers about design features unique to MitraClip™ therapy
1:00 p.m. – 2:00 p.m.
Physiology
Coronary Microvascular Dysfunction: Clarifying the Confusion on the Microcirculation
Abbott HUB #3 Theater | Exhibit Hall
Presenters: Samit Shah, MD; Allen Jeremias, MD
Next-Level Engagement: Discussion on the importance of CMD testing and how to interpret and assess results
2:18 p.m. – 2:29 p.m.
Transcatheter Mitral
TENDYNE™ SUMMIT Pivotal Trial Roll-in and MAC Arm Outcomes
Moscone South | Innovation & Clinical Science Theater | Hall B
Presenters: Jason H. Rogers, MD; Vinod H. Thourani, MD
Caution: TENDYNE™ is an investigational device. Limited by Federal (U.S.) law to investigational use only and not available for sale.
2:36 p.m.– 2:54 p.m.
Transcatheter Tricuspid
TRILUMINATE™ Pivotal Trial: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation
Moscone South | Innovation & Clinical Science Theater | Hall B
Presenter: David H. Adams, MD
CAUTION: Investigational Device. Limited by Federal (U.S.) law to investigational use only.
3:00 p.m. – 4:00 p.m.
Intravascular Imaging
The Future of Imaging with ULTREON™ 2.0 Software
Abbott HUB #3 Theater | Exhibit Hall
Presenters: Richard Shlofmitz, MD; Ziad Ali, MD
Next-Level Engagement: A hands-on workshop showing the advancement of Ultreon 2.0 Software vs. AptiVue Imaging Software
3:12 p.m. – 3:30 p.m.
Transcatheter Mitral
One-Year Outcomes with Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair from EXPAND G4 Late-Breaking Science
Moscone South | Innovation & Clinical Science Theater | Hall B
Presenter: Ralph Stephan von Bardeleben, MD, PhD
3:30 p.m.
TAVI
LIVE Case: University of Pittsburgh Medical Center, Pittsburgh, PA - TAVR
Moscone North | Structural Theater | Hall F | Exhibit Level
Presenter: Ibrahim Sultan, MD, FACS, FACC
5:00 p.m. – 5:30 p.m.
TAVI | Vessel Closure
Access-Site Management for TAVI: Why Suture-Mediated Closure is My First Choice
Abbott HUB #3 Theater | Exhibit Hall
Presenter: Rahul Sharma, MBBS, FRACP
Next-Level Engagement: Hands-on deployment of Perclose™ ProStyle™ Device
5:30 p.m. – 6:00 p.m.
TAVI
The Future of TAVI and the ENVISION Trial
Abbott HUB #3 Theater | Exhibit Hall
Presenter: Rishi Puri, MD
Next-Level Engagement: Discussions around ENVISION Trial with steering committee
Wednesday, October 25
9:00 a.m.– 10:00 a.m.
Thrombectomy
JETi™ Hydrodynamic Thrombectomy: A Dual-Action Design for Efficient Clot Removal
Abbott HUB #3 Theater | Exhibit Hall
Presenter: Mehdi Shishehbor, MD
Next-Level Engagement: Hands-on simulation of clot removal with JETi™ Hydrodynamic Thrombectomy System
11:00 a.m. – 12:00 p.m.
Intravascular Imaging
Simplify the Complex With OCT
Abbott HUB #3 Theater | Exhibit Hall
Presenters: Gregg Stone, MD; Ajay Kirtane, MD
11:00 a.m. – 11:21 a.m.
Endovascular
Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial
Moscone South | Innovation & Clinical Science Theater | Hall B
Presenter: Ramon L. Varcoe, MBBS, MS, PhD, MMed
Caution: Esprit™ BTK Everolimus Eluting Resorbable Scaffold System is an investigational device. Limited by Federal (U.S.) law to investigational use only and not available for sale.
1:00 p.m. – 2:00 p.m.
Endovascular
Drug-Coated Balloons – Time to Unveil What You’re Not Seeing
Abbott HUB #3 Theater | Exhibit Hall
Presenter: Kenneth Rosenfield, MD
Next-Level Engagement: Get your badge scanned to receive updates on the SurVeil‡ Drug-Coated Balloon
2:00 p.m. – 3:00 p.m.
Orbital Atherectomy
Orbital Atherectomy Symposium - “A Global Perspective On Procedural Strategies For Severely Calcified Lesions”
Moscone South | Level 2 | Presentation Theater 1
Presenters: Hayder Hashim, MD (Moderator); Jennifer Rymer, MD; Jacques Monsegu, MD, PhD; Takashi Ashikaga, MD; Naresh Solankhi, MD; Ravi Sharma, MD
3:00 p.m. – 4:00 p.m.
Intravascular Imaging
Identifying and Managing Calcified Lesions
Abbott HUB #3 Theater | Exhibit Hall
Presenters: Evan Shlofmitz, MD; Kathleen Kearney, MD
Next-Level Engagement: Interactive session, with live product demo, describing the role of OCT and orbital atherectomy in assessing and managing calcified lesions
3:43 p.m. – 3:50 p.m.
Transcatheter Tricuspid
TRILUMINATE™ Pivotal Imaging Sub-study: Insights from CT and MRI
Moscone South | Innovation & Clinical Science Theater | Hall B
Presenter: João L. Cavalcante, MD
CAUTION: Investigational Device. Limited by Federal (U.S.) law to investigational use only.
4:00 p.m. – 5:00 p.m.
Endovascular
Expanding and Implementing Health Equity in Clinical Trials – Impact on Diversity and Inclusion
Abbott HUB #3 Theater | Exhibit Hall
Presenters: Jennifer Jones-McMeans; Sahil A. Parikh, MD; Natalia Pinilla-Echeverri, MD; Danielle R. Bajakian, MD; Megan Coylewright, MD; Akilah Cadet; Jennifer Meinen (Moderator)
Next-Level Engagement: Discussions around expanding and implementing healthy equity in clinical trials
5:00 p.m. – 6:00 p.m.
Endovascular
LIFE-BTK Office Hours
Abbott HUB #3 Theater | Exhibit Hall
Presenters: Ramon Varcoe, MBBS, MS, PhD, MMed;, Brian DeRubertis, MD, FACS;, Sahil Parikh, MD, FSCAI;, Danielle Bajakian, MD;, Chris Metzger, MD; Lawrence Garcia, MD, FACC, FAHA, FSCAI
Next-Level Engagement: The LIFE-BTK Office Hours will be a time for physicians to meet with the investigators and Abbott Clinical Science and Med Affairs experts to discuss the LIFE-BTK trial results
Thursday, October 26
9:00 a.m.– 10:00 a.m.
Endovascular
Carotid Artery Stenting and the National Coverage Decision
Abbott HUB #3 Theater | Exhibit Hall
Presenter: Christopher Metzger, MD
Next-Level Engagement: Hands-on deployment of XACT™ Carotid Stent System and Emboshield NAV6™ System
Important Safety Information (XACT™ Carotid Stent System)
Important Safety Information (Emboshield NAV6™ System)
11:00 a.m. – 11:30 a.m.
TAVI
The Future of TAVI and Lifetime Management
Abbott HUB #3 Theater | Exhibit Hall
Presenters: Sahil Khera, MD, MPH
Next-Level Engagement: Interactive discussion, with the Navitor valve, sharing procedural applicability and lifetime management decisions
11:22 a.m. – 11:44 a.m.
Transcatheter Tricuspid
Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients With Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE™ Pivotal Trial
Moscone South | Innovation & Clinical Science Theater | Hall B
Presenter: Suzanne V. Arnold, MD
CAUTION: Investigational Device. Limited by Federal (U.S.) law to investigational use only.
11:30 a.m.– 12:00 p.m.
LAAO
Versatility of the Amulet™ Occluder Adapting to Various LAA Morphologies
Abbott HUB #3 Theater | Exhibit Hall
Presenter: Rahul Sharma, MBBS, FRACP
Next-Level Engagement: Discussion around the Amulet occluder’s versatility in a broad range of LAA morphologies and a product demo
1:00 p.m. – 2:00 p.m.
Intravascular Imaging
Review of the Latest OCT Data and AI-Driven Solution
Abbott HUB #3 Theater | Exhibit Hall
Presenter: Evan Shlofmitz, MD
Next-Level Engagement: Discussions around the usage of AI, OCT and imaging data
3:00 p.m. – 4:00 p.m.
PCI
XIENCE™ Stent System: The use of Clinical Evidence and Artificial Intelligence (AI) to Personalize DAPT Treatment Regimen
Abbott HUB #3 Theater | Exhibit Hall
Presenters: Roxana Mehran, MD; Hirotoshi Watanabe, MD
Next-Level Engagement: Discussions around the usage of AI to personalize DAPT regimen
Indications
Applies to XIENCE Skypoint™, XIENCE Sierra™ and XIENCE Alpine™ Stent Systems:
- Indicated for improving coronary artery luminal diameter in patients, including those at high risk for bleeding and those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary artery lesions (length ≤ 32 mm) with reference vessel diameters of ≥ 2.25 mm to ≤ 4.25 mm.
- Treating de novo chronic total coronary occlusions.
In addition, XIENCE Skypoint™ Stent System is indicated with reference vessel diameters of ≥ 2.25 mm to ≤ 5.25 mm.